Cardiorenal Forum Annual Scientific Meeting: Practical considerations in managing patients with cardiorenal disease

Cardiorenal Forum 16th Annual Scientific Meeting
Friday 8th October 2021 10.30 – 15.10 BST

Practical considerations in managing patients with cardiorenal disease


We hope healthcare professionals will join us virtually for our popular annual scientific meeting, which will be broadcast live this year and free to attend. The meeting will focus on improving the care we deliver to patients with a broad spectrum of cardiorenal disease, incorporating an evidence-based approach.

Targets, treatments and new data with a particular focus on heart failure, diabetes, chronic kidney disease (CKD) and lipid management will be discussed by speakers from centres around the UK. Practical workshops on the presentations will be an integral part of this year’s programme. These will feature cases and discussion of service delivery.

The day will be hosted by a multidisciplinary faculty in the studio, who will pose your questions to the experts, lead the discussion and contribute to the workshops.

Funding

This independent meeting will be supported and funded by a number of pharmaceutical companies.

Is it for me?

This meeting is for healthcare professionals. It is aimed at anyone treating the cardiorenal patient particularly those working in heart failure, cardiology, nephrology, diabetes, lipids, endocrinology, care of the elderly, general medicine, general practice, clinical pharmacy and allied disciplines.

Accreditation

4 CPD/CME credits
The Cardiorenal Forum has assigned 4 hours of CPD/CME credit to this meeting. Certificates of attendance will be sent after the meeting.

Endorsements

The Cardiorenal Forum Annual Scientific Meeting is supported by KDIGO (Kidney Disease Improving Global Outcomes)






Programme
  •   Our studio chairs for the day:
  •   Dr Sarah Birkhoelzer, Cardiology Registrar, Queen Alexandra Hospital, Portsmouth
      Professor Paul Kalra, Consultant Cardiologist, Portsmouth Hospitals NHS Trust
      Professor Philip Kalra, Consultant Nephrologist, Salford Royal NHS Foundation Trust; Professor of Renal Medicine, University of Manchester
      Dr Smeeta Sinha, Consultant Nephrologist, Salford Royal NHS Foundation Trust; Honorary Lecturer, University of Manchester
      Dr Sue Piper, Consultant Cardiologist, King’s College Hospital NHS Trust, London
   
10.30 – 12.00 SESSION 1:
UNDERSTANDING THE EVIDENCE BASE OF DIABETES DRUGS IN HEART FAILURE AND CKD
  •   Introduction


  •   Presentations
  •   SGLT2 inhibitors in heart failure: the facts
      Dr Rosita Zakeri, Consultant Cardiologist, King’s College Hospital, London
  •   SGLT2 inhibitors in CKD: the facts
      Dr Smeeta Sinha, Consultant Nephrologist, Salford Royal NHS Foundation Trust; Honorary Lecturer, University of Manchester
  •   GLP-1 receptor agonists in cardiorenal disease: the facts
      Dr Amar Puttanna, Consultant in Diabetes and Endocrinology, Good Hope Hospital, Birmingham
  •   Discussion/Q&As
      Panel discussion between speakers and studio faculty including your questions


  •  
  •   Practical workshops on diabetes drugs
  •   Workshop 1: New diabetes drugs in heart failure
    •   Dr Sarah Birkhoelzer, Cardiology Registrar, Queen Alexandra Hospital, Portsmouth
        Dr Amar Puttanna, Consultant in Diabetes and Endocrinology, Good Hope Hospital, Birmingham
        Ms Maggie Simpson, Nurse Specialist, NHS National Services Scotland
        Dr Rosita Zakeri, Consultant Cardiologist, King’s College Hospital, London



  •   Workshop 2: New diabetes drugs in chronic kidney disease
    •   Dr Amar Puttanna, Consultant in Diabetes and Endocrinology, Good Hope Hospital, Birmingham
        Dr Smeeta Sinha, Consultant Nephrologist, Salford Royal NHS Foundation Trust; Honorary Lecturer, University of Manchester
        Other participants (tbc)



   
12.05 – 13.00 SESSION 2:
PRACTICAL APPROACHES TO DIFFICULT ASPECTS OF LIPID MANAGEMENT AND HOW TO OPTIMISE BONE METABOLISM
  •   Introduction


  •   Presentations
  •   What you need to know: advances in lipid medicine
      Dr Paul Hamilton, Consultant Chemical Pathologist, Belfast Health and Social Care Trust
  •   What you need to know: bone metabolism
      Sir John Cunningham, Professor of Nephrology, University College London
  •   Discussion/Q&As
      Panel discussion between morning speakers and studio anchors including questions from viewers


  •   13.00 – 13.30 Break


   
13.30 – 15.05 SESSION 3:
HOT TOPICS IN CARDIORENAL DISEASE
  •   Introduction


  •   Hot topic 1: Iron
  •   Presentation: Latest developments in iron deficiency and CKD
      Dr Austin Chukwu, Research Fellow, Salford Royal NHS Trust and Professor Phil Kalra, Professor of Renal Medicine, University of Manchester; Consultant Nephrologist, Salford Royal NHS Trust
  •   Workshop: the practicalities of how to deliver an IV iron service (including lessons learned from COVID)
    •   Dr Matt Dewhurst, Consultant Cardiologist, North Tees and Hartlepool NHS Foundation Trust
        Ms Sue Scott, Transfusion Nurse Practitioner, Haematology Department, Royal United Hospital Bath NHS Foundation Trust
        Professor Phil Kalra, Professor of Renal Medicine, University of Manchester; Consultant Nephrologist, Salford Royal NHS Trust

  •   Discussion/Q&As

  •   Hot topic 2: Anticoagulation
  •   Presentation: Anticoagulation: turning it on and off
      Dr Sara Boyce, Consultant Haematologist, University Hospital Southampton
  •   Workshop: Tough decisions around anticoagulation and the frail, elderly patient
    •   Dr Sara Boyce, Consultant Haematologist, University Hospital Southampton
        Dr Shirley Sze, NIHR Academic Clinical Lecturer in Cardiology, University Hospitals of Leicester NHS Trust
        Other participants (tbc)

  •   Discussion/Q&As
  •   Summing up of day
  •   15.10 Meeting close


   
Chairpersons

Dr Sarah Birkhoelzer Cardiology Registrar (ST4), Queen Alexandra Hospital, Portsmouth

Sarah is the British Junior Cardiologists’ Association (BJCA) Women in Cardiology (WIC) and Flexible Training Representative. Her interests include cardiovascular imaging and heart failure. Sarah is also a member of the Scientific Committee of the Cardiorenal Forum

Professor Paul Kalra Consultant Cardiologist, Portsmouth Hospitals NHS Trust

Paul is a Consultant Cardiologist at Portsmouth Hospitals NHS Trust, and an Honorary Professor of Cardiology. His research interests include the role of iron deficiency and its correction in patients with heart failure, cardiorenal disease and the impact of hyperkalaemia on RAAS inhibition use. He is one of the founders of the Cardiorenal Forum and past Chair of the British Society for Heart Failure

Professor Philip Kalra Consultant Nephrologist, Salford Royal NHS Foundation Trust; Professor of Renal Medicine, University of Manchester

Philip graduated from Cambridge University and is Professor of Nephrology in Salford and the University of Manchester. He has been a Consultant Nephrologist since 1995, working at the Salford Royal NHS Foundation Trust. He has major research focus on renovascular disease, cardiovascular disease in chronic kidney disease (CKD), CKD progression and iron use in CKD, and he leads the research team in Salford. He was Academic Vice President of the UK Renal Association from 2016–19, Chair of the UK Kidney Research Consortium during this time and was Chair of the NIHR CRN Renal Disorders group from 2010–18. He has been involved in the development of several large UK clinical trials in nephrology and cardiology, including the ASTRAL, PIVOTAL and IRONMAN trials, and he has played a role in amalgamating Cardiorenal education and research within the UK

Dr Sue Piper Consultant Cardiologist, King’s College Hospital NHS Trust, London

Sue is committed to ensuring high quality heart failure care for all through innovation, education, training and clinical excellence. She is Chair of the Pan London Heart Failure Steering Group, Chair of the British Society for Heart Failure sub-committee for Education, a Member of European Society of Cardiology Heart Failure Association examination committee, and of the Heart Failure Association Patient Care committee

Dr Smeeta Sinha Consultant Nephrologist, Salford Royal NHS Foundation Trust; Honorary Senior Lecturer, University of Manchester

Smeeta is the NHS England/Improvement National Clinical Advisor for Chronic Kidney Disease (CKD), which is one of the five work streams that make up the National Renal Service Transformation Programme. She is also Chair of the North West NHS England/Improvement Renal Network. Her clinical interests are in CKD and multi-morbidity including diabetic kidney disease and cardiorenal syndrome. She also leads the glomerulonephritis service at Salford Royal. Smeeta’s research interests include vascular calcification, multi-morbidity, glomerulonephritis and rare renal diseases. She is a recognised international key opinion leader in the field of calciphylaxis and, despite the challenges of conducting research in the rare disease space, has supported the development and delivery of clinical trials including phase 1 -3 studies